The global neurological biomarkers market is experiencing significant growth as healthcare providers, pharmaceutical companies, and research organizations increasingly recognize the importance of accurate disease detection and personalized treatment. Neurological Biomarkers Market help identify disease-related biological changes, assess disease progression, estimate patient risk, and monitor...
The neurological biomarkers market is entering a transformative phase as healthcare and pharmaceutical research increasingly seek faster, more precise, and less invasive ways to understand neurological disorders. Biomarkers are becoming important not only for diagnosis but also for determining disease progression, evaluating treatment response, supporting patient stratification, and improving...
The Telestroke Market is entering a period of rapid expansion as rising stroke incidence, neurologist shortages, and unequal access to specialized care increase the need for remote stroke management. The global market was estimated at USD 1.77 billion in 2024 and is projected to reach USD 5.49 billion by 2033, registering a 13.15% CAGR from 2025 to 2033.
North...
Proteomics is transforming healthcare by enabling researchers to study the complete set of proteins within cells, tissues, and biological systems. Since proteins directly influence how diseases develop and respond to treatment, proteomics has become an essential component of modern biomedical research. Across the Asia-Pacific region, healthcare organizations, research institutes, and...
The global Refurbished Medical Imaging Device market, valued at USD 12.80 Billion in 2025, is expected to reach USD 23.70 Billion by 2035, registering a revenue CAGR of 6.3% during the forecast period. Demand is increasing as healthcare providers seek affordable imaging systems to expand diagnostic capacity while managing capital expenditure. Rising rates of chronic diseases, an aging global...
Companion Animal Genetics Market: Industry Trends, Growth Analysis & Forecast to 2033
Companion Animal Genetics Market is transforming modern pet healthcare by enabling early disease detection, personalized treatment plans, and responsible breeding practices. Genetic testing has become an essential tool for veterinarians, breeders, and pet owners seeking to identify inherited...
Artificial intelligence (AI) is reshaping healthcare by enabling faster, more consistent, and data-driven diagnostic processes. From interpreting medical images to assisting physicians with clinical decision-making, AI-powered diagnostic tools are becoming an integral part of modern healthcare systems. As healthcare providers manage increasing patient volumes and more complex diseases, AI is...
The global molecular imaging market is witnessing steady growth as healthcare providers increasingly adopt advanced diagnostic technologies to enable earlier disease detection and improve patient outcomes. Valued at USD 8.92 billion in 2025, the market is projected to reach USD 12.94 billion by 2034, expanding at a CAGR of 4.22% during the forecast period.
Molecular imaging has become an...
The global PET Scanners Market was valued at USD 2.04 billion in 2023 and is projected to reach USD 3.37 billion by 2030, expanding at a CAGR of 3.65% from 2024 to 2030. Market growth is primarily driven by continuous advancements in positron emission tomography (PET) imaging technology, increasing adoption of precision diagnostics, rising demand for radiopharmaceutical analysis, and...
The global Neurosurgery Device Market is experiencing significant growth as the prevalence of neurological disorders, traumatic brain injuries, spinal conditions, and brain tumors continues to increase worldwide. Neurosurgery devices are specialized medical instruments used for diagnosing, monitoring, and performing surgical procedures involving the brain, spine, and nervous system....
Breakthroughs in biomedical engineering, robotics, and regenerative medicine are redefining the future of healthcare by improving the quality of life for patients with organ failure and physical disabilities. Artificial organs and bionic devices are enabling healthcare providers to restore lost functions, extend patient survival, and deliver more personalized treatment solutions. As demand for...
The global Blood-Based Biomarker For Alzheimer’s Disease Diagnostics Market was valued at USD 169.2 million in 2025 and is projected to grow from USD 194.8 million in 2026 to USD 529.9 million by 2033, registering a CAGR of 17.4% from 2026 to 2033. North America dominated the global market with a 43.0% revenue share in 2025, driven by regulatory approvals, expanding clinical...